Yashica Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
- Revenue Growth 104.64%
- Profit Growth 246.73%
- Ebitda 917.32%
- Net Worth 10.93%
- Total Assets 16.28%
About Yashica Pharmaceuticals
Yashica Pharmaceuticals Private Limited (YPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 November 2007 and has a history of 17 years and three months. Its registered office is in Kalyan West, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Vaishali Totare and Sanjay Totare serve as directors at the Company.
Company Details
-
Location
Kalyan West, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2007PTC175913
-
Company No.
175913
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Nov 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Yashica Pharmaceuticals Private Limited offer?
Yashica Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Laxatives, Common Disease Medicines, Antihistamines, Anaemia Medicine, Anti Infective Drugs & Medicines, Antibiotic Injection, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Ayurvedic & Herbal Extracts.
Who are the key members and board of directors at Yashica Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaishali Totare
|
Director | 15-Nov-2007 | Current |
|
Sanjay Totare
|
Director | 15-Nov-2007 | Current |
Financial Performance of Yashica Pharmaceuticals.
Yashica Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 104.64% increase. The company also saw a substantial improvement in profitability, with a 246.73% increase in profit. The company's net worth Soared by an impressive increase of 10.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yashica Pharmaceuticals?
In 2023, Yashica Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Perivinc Pharmaceuticals Private LimitedVaishali Totare and Sanjay Totare are mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2023 | Axis Bank Limited | ₹2.00 Cr | Open |
How Many Employees Work at Yashica Pharmaceuticals?
Unlock and access historical data on people associated with Yashica Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yashica Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yashica Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.